TL;DR When growth slows after a decent launch, the reflex is to buy more marketing, more salespeople, or more funding. Usually, the real constraint is upstream — unclear positioning, weak differentiation, or no compelling reason for the buyer to act. Slow growth is feedback about your strategy, and the fix starts with an honest diagnosis, not a bigger lead-gen budget.
From the LifeSci Continuum podcast: In my conversation with Nathalya Mamane and Dr. Michael Mina of Anywhere Dx, one idea ran underneath everything they said. Successful companies stay close to the customer's actual problem, and the ones that struggle drift toward talking about their own technology instead.
Dr. Mina is a physician. So the framing that kept occurring to me during our conversation was a clinical one.
No good doctor prescribes before they diagnose.
Yet that's exactly what most companies do when growth slows down. They reach for the treatment they already have in the cabinet — a campaign, a hire, a raise — before they've done the work to figure out what's actually wrong. And treating the wrong problem doesn't just waste money. It costs you the time you could have spent fixing the real one.
What does a growth slowdown usually look like?
It rarely looks like failure. That's what makes it so easy to misread.
The product launched. The feedback is positive. People like the demos and say encouraging things in meetings. Revenue is growing. It's just growing far slower than the plan said it would, and no one can quite explain why.
So the team does what teams do. It looks for the missing ingredient.
We need more marketing. We need more salespeople. We need more funding to do both. Every one of those can be the right answer, and sometimes it is. If you have a great offer, clear positioning, and a repeatable sale, then pouring fuel on it is exactly right.
But that's not usually the situation I get called into. More often, the machine that's supposed to turn attention into revenue has a problem somewhere in the middle, and adding more attention at the top just widens the leak.
Here's the part that's hard to hear. Slow growth is information. The market is telling you something specific, and "we need more leads" is often the least accurate way to read the message.
Why is more marketing usually the wrong first move?
Because marketing amplifies whatever is already true about your business. If the underlying strategy is sound, marketing multiplies it. If the positioning is muddy or the value isn't landing, marketing multiplies that too, at a higher cost.
Think about what more marketing actually does. It brings more people to the same message, the same website, the same sales conversation, and the same offer. If those are converting poorly, more traffic doesn't fix the conversion. It just means you're now paying to expose the problem to a larger audience.
I've watched companies respond to a slowdown by tripling ad spend and rebuilding the website, twice, while the real issue sat untouched. The real issue was that no one could clearly say why this product, for this customer, right now. No campaign fixes that, because the campaign isn't where it broke.
This is the trap. A growth problem shows up as a marketing symptom — soft pipeline, low conversion, long cycles — so it gets treated as a marketing problem. The visible symptom and the actual cause are in different places, and spending against the symptom is expensive and slow.
Which is why I treat a slowdown the way a clinician treats a presenting complaint. The symptom tells you where to start looking. It doesn't tell you what's wrong yet.
How do you diagnose what's actually constraining growth?
You work through the system in order, from the customer inward, and you resist the urge to jump to a treatment. A few questions do most of the diagnostic work. Ask them honestly and the real constraint usually surfaces fast.
Are we selling to the right customer? Growth often slows because the company is aimed at a segment that's a poor fit — too hard to reach, too slow to buy, or not feeling the problem acutely enough to act. Sometimes a real subset of your customers is buying quickly and happily, and the growth answer is to go find more of exactly them instead of chasing everyone. This is where honest market research earns its cost, because it separates the buyers who love you from the ones you wish loved you.
Does the customer even agree they have the problem? If you're selling a solution to a problem the buyer hasn't named yet, your sale is twice as long and half as likely. You're not just competing with alternatives. You're competing with "we're fine, this isn't urgent." Growth is slow when the market hasn't accepted the problem you solve as a problem worth solving now.
Does your positioning actually set you apart? If a buyer can't tell in a sentence how you're different from the three other options on their list, you don't have a differentiation they can act on. Sameness is a growth killer, because a buyer who can't distinguish the options defaults to the safest or cheapest one, or to doing nothing. Sharp positioning is often the highest-impact fix available, and it costs a fraction of a demand-gen program.
Is your price aligned with the value the buyer perceives? Pricing that's disconnected from perceived value slows growth in both directions. Too high for the value a buyer sees and deals stop moving. Too low and you signal the product is a nice-to-have, not a serious tool. The issue is rarely the number itself. It's whether the value is legible enough to justify it.
Are you selling outcomes, or listing features? Technical teams drift toward describing what the product does. Buyers care about what changes for them. If your sales story leads with specifications instead of the result the customer gets, you're making the buyer do the translation, and many won't bother.
Where does adoption actually break down? Map the real path from first contact to routine use and find the step where people fall out. Sometimes growth isn't a top-of-funnel problem at all. It's a champion who can't get internal consensus, or an onboarding step that loses half the people who start it. Journey mapping exists to find exactly these breakpoints.
Are you even measuring the right things? If the only number anyone watches is leads, you'll diagnose every problem as a lead problem. You need to see conversion by stage, cycle length, win and loss reasons, and where deals die. The metrics you track determine the problems you're able to see.
None of these require more budget to answer. They require the willingness to look honestly at the parts of the business that are less fun to examine than a new campaign.
Why does growth get blamed on marketing when it's usually strategic?
Because marketing is where the strategy becomes visible.
A positioning problem doesn't announce itself as a positioning problem. It shows up as ads that don't convert and a sales team that keeps losing to "no decision." A weak reason-to-buy doesn't show up in a strategy review. It shows up as long, drifting sales cycles. By the time a strategic weakness reaches a dashboard, it's wearing a marketing costume, so marketing takes the blame.
This is well documented on the buying side. Matthew Dixon and Ted McKenna, in The JOLT Effect, analyzed more than 2.5 million sales conversations and found that 40 to 60 percent of qualified deals are lost to "no decision" rather than to a competitor — the buyer wanted to act and couldn't get to a confident yes (Dixon discusses the research here). Read that as a growth diagnosis and it's damning. A huge share of soft growth isn't a competitor beating you. It's your would-be buyer unable to make the case internally, because you didn't give them a reason clear and safe enough to carry.
The complexity underneath makes it worse. Gartner's research on the B2B buying journey found that 99% of B2B purchases are driven by some organizational change, and that a growing buying group has to reach consensus across people with different goals before anyone signs. If your value isn't clear enough to survive being explained secondhand to a skeptical committee, your growth is capped no matter how many leads you generate.
So marketing is the messenger. The message is usually about strategy.
What does treating growth like a diagnosis actually change?
It changes the order of operations, and the order is the whole point.
The default approach prescribes first and diagnoses never. Growth is soft, so we run a treatment — more spend, more headcount — and hope the numbers move. When they don't, we run a different treatment. It's the business equivalent of trying medicines at random and watching for a reaction.
The diagnostic approach reverses that. You find the constraint first, then apply the specific fix it calls for. If the constraint is positioning, no amount of sales hiring fixes it, and sharpening the message might get the whole funnel moving. If the constraint is the wrong target customer, better ads just bring more of the wrong people faster. Match the treatment to the diagnosis and cheap changes often produce outsized results, because you're finally fixing the thing that was actually holding you back.
A quick way to feel the difference: picture two companies with the same soft quarter. The first adds a salesperson and doubles ad spend, and six months later has a bigger cost base and the same conversion rate. The second spends two weeks on win/loss interviews, learns that buyers can't tell it apart from a cheaper competitor, rewrites its positioning, and watches its close rate move without adding a dollar of media. Same symptom, opposite outcome, and the only difference was diagnosing before treating.
It also protects you from the most expensive mistake in growth, which is scaling a broken model. Pouring money into a machine that converts poorly doesn't get you growth. It gets you a bigger, more expensive version of the same disappointing result, and it burns the runway you needed to find the real fix. The time to add fuel is after the engine runs clean, not before.
Where a strategic growth advisor changes the conversation
When founders bring me a growth problem, they often expect a conversation about campaigns, channels, and lead volume. That's rarely where I spend my time.
As a strategic growth advisor and fractional CMO, I ask a different and less comfortable set of questions first:
Are we actually solving the right problem, or one the market doesn't feel urgently?
Is this the right customer, or a segment that will always be slow and expensive to win?
Is the product positioned so a buyer can tell in one sentence why it's different?
Where exactly is adoption breaking down between interest and routine use?
What is stopping a genuinely interested buyer from saying yes today?
Fix those, and most of what looked like a marketing problem gets easier on its own. Conversion improves because the message is clear. Cycles shorten because the reason to act is obvious. Referrals grow because the value is legible enough to pass along. You often need less marketing spend after the diagnosis, not more, because the spend finally lands on a message that works.
The reason this usually needs an outside voice is the same reason it's hard to read an X-ray of your own arm. When you've lived inside the company for years, the muddy positioning sounds clear to you, the awkward sales story sounds natural, and the wrong-customer strategy feels like commitment. An outside partner's job is to see the business the way your buyer sees it, name the constraint plainly, and connect the customer, the real job, and the go-to-market before you spend another quarter treating the wrong thing.
That's the work. Diagnose honestly, fix the constraint, then scale what's finally working.
The founder takeaway
Growth problems rarely begin in marketing. Marketing is usually just where they become visible.
When the numbers come in soft, the useful instinct isn't "what campaign do we run?" It's "what is the market telling us, and where is the actual constraint?" Answer that first and the treatment becomes obvious, and often cheaper than the campaign you were about to fund.
Anywhere Dx keeps its growth honest by staying anchored to a real problem a real customer feels. That's the same discipline that gets a stuck company moving again. Find the problem, get specific about the customer, and make the reason to act impossible to miss.
Frequently asked questions
Why is our revenue growing but slower than expected?
Usually, because a constraint upstream of marketing — positioning, target customer, or reason to buy — is capping conversion. More leads flow into the same bottleneck, so growth stays soft until you fix the constraint itself.
Should we hire more salespeople to grow faster?
Only if the sale is already repeatable and the constraint is capacity. If reps are losing deals to "no decision" or unclear differentiation, more reps reproduce the same loss at higher cost.
How do I know if it's a marketing problem or a strategy problem?
Look at where deals die. Poor top-of-funnel response points to message or targeting. Deals that engage and then go nowhere usually point to positioning, value, or a missing reason to act — strategy, not lead volume.
What's the single most common cause of slow growth?
Weak differentiation. When a buyer can't quickly say why you're different, they default to the safest, cheapest option or to doing nothing — which shows up as long cycles and lost deals.
Does pricing affect growth more than we think?
Often. Price signals seriousness and has to line up with the value the buyer perceives. The usual fix isn't a different number but making the value clear enough to justify the one you have.
How long before we know if a fix is working?
Strategic fixes like positioning show up first in sales-conversation quality and conversion by stage, often within a quarter — well before they fully register in top-line revenue. Watch the stage metrics, not just the total.
Where to start
If growth has slowed, resist the assumption that you have a marketing problem. You may have found a strategic one, and that's better news than it sounds, because strategic fixes are usually cheaper and faster than the spending you were about to do.
Bring me the numbers that aren't adding up. We'll find the real constraint before you spend against the wrong one.
